News Quantified

JNJ – johnson & johnson (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

J&J Stock Up 38% in 6 Months: Should You Buy, Sell or Hold? [Yahoo! Finance]

2 Reasons I'd Happily Hold Johnson & Johnson Through Any Market Crash [Yahoo! Finance]

Johnson And Johnson Faces Fresh Talc Verdict As Pipeline Story Evolves [Yahoo! Finance]

AstraZeneca News On Cancer And Asthma Raises New Questions For Investors [Yahoo! Finance]

Early study results from Johnson & Johnson show promising antitumor activity with combination of pasritamig and docetaxel in advanced prostate cancer [Yahoo! Finance]

1.4%

BEAT

0.1%

BEAT

5.1%

BEAT

-1.2%

BEAT

Form 144 JOHNSON & JOHNSON Filed by: Decker Robert J

Form 4 JOHNSON & JOHNSON For: Feb 20 Filed by: Schmid Timothy

Form 144 JOHNSON & JOHNSON Filed by: Schmid Timothy

Form 4 JOHNSON & JOHNSON For: Feb 13 Filed by: Swanson James D.

Form 4 JOHNSON & JOHNSON For: Feb 13 Filed by: Mulholland Kristen

Top News Gainers

3/27 Form DEFA14A JOHNSON & JOHNSON 8.1%

3/12 Paul Harris' Top Picks: March 12, 2020 [Business News Network (BNN) Energy & Resources (Canada)] 7.5%

4/7 Is JNJ Stock A Buy On CEO's Bullish Call For Coronavirus Vaccine? [Investor's Business Daily] 4.6%

4/5 Will These 3 Coronavirus Stocks Lead the Market to Recovery? [Yahoo! Finance News] 4.3%

4/13 Stocks slip as market enters new phase, with investors worrying about balance sheets [CNBC] 4.0%

3/2 AODocs Joins AIIM Leadership Council, Showcases Innovative Approach to Information Management at 2020 AIIM Conference 3.9%

3/4 Johnson & Johnson ordered to pay $1.7 million to three Australian women in pelvic mesh class action [Reuters] 3.8%

3/18 Is This 1 Healthcare Stock Coronavirus-Proof? [The Motley Fool] 3.8%

3/24 What Technology And Manufacturing Can Do To Help Against COVID-19 [Forbes] 3.6%

4/1 5 of the Best Stocks to Buy for April [Yahoo! Finance News] 3.3%

Top News Decliners

3/21 Johnson and Johnson: A Safe Haven in Recession [The Motley Fool] -7.3%

3/20 Is Johnson & Johnson (NYSE:JNJ) Trading At A 35% Discount? [Yahoo! Finance News] -6.9%

3/10 J&J MET antibody nabs accelerated review status for certain lung cancer patients [Seeking Alpha] -6.8%

3/18 J&J files U.S. application for MS med ponesimod [Seeking Alpha] -6.6%

10/18 Wolves In Sheep’s Clothing: We Can’t Trust Businesses To Do Right By Americans Now [Forbes] -6.4%

5/28 Oklahoma taking on Johnson & Johnson in historic trial [MSNBC.com] -6.1%

3/13 Americans rush to stock up on essentials as coronavirus spreads [Reuters] -5.5%

3/11 Desperate to exit, a $10B price tag for Magic Leap is crazy [TechCrunch Blog] -4.9%

7/12 Johnson & Johnson (NYSE: JNJ) is now covered by analysts at Credit Suisse Group AG. They set an "outperform" rating and a $156.00 price target on the stock. -4.5%

3/6 Eyecare industry leaders sign Proclamation to focus on key issues facing the future of optometry -3.8%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day